Liminatus Pharma logo

Liminatus Pharma Share Price (NASDAQ: LIMN)

$2.74

-0.02

(-0.72%)

Last updated on

Check the interactive Liminatus Pharma Stock chart to analyse performance

Liminatus Pharma stock performance

as on August 30, 2025 at 1:29 am IST

  • Today's Low:$2.64
    Today's High:$2.74

    Day's Volatility :3.65%

  • 52 Weeks Low:$2.53
    52 Weeks High:$33.66

    52 Weeks Volatility :92.48%

Liminatus Pharma Stock Returns

PeriodLiminatus Pharma IncIndex (Russel 2000)
3 Months
-49.63%
0.0%
6 Months
-73.04%
0.0%
1 Year
-73.04%
0.0%
3 Years
-73.04%
-4.7%

Liminatus Pharma Inc Key Stats

Check Liminatus Pharma key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$2.76
Open
$2.71
Today's High
$2.74
Today's Low
$2.64
Market Capitalization
$145.2M
Today's Volume
$1.2M
52 Week High
$33.66
52 Week Low
$2.53
Revenue TTM
$0.0
Earnings Per Share (EPS)
$-0.16
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Liminatus Pharma Stock including INR - Dollar returns

The Liminatus Pharma stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Liminatus Pharma investment value today

Current value as on today

₹32,494

Returns

₹67,506

(-67.51%)

Returns from Liminatus Pharma Stock

₹72,790 (-72.79%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Liminatus Pharma Stock

19.15%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Investment in Liminatus Pharma Shares from India has grown by 19.15% over the past 30 days, indicating increased transactional activity.

78%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Liminatus Pharma Stock from India on INDmoney has increased by 78% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Liminatus Pharma Stock

Rating
Trend

Liminatus Pharma Stock Insights

  • Price Movement

    In the last 7 days, LIMN stock has moved down by -20.4%

Liminatus Pharma Technicals Summary

Sell

Neutral

Buy

Liminatus Pharma is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Liminatus Pharma Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Liminatus Pharma Inc logo
-54.22%
-73.04%
-73.04%
-73.04%
-73.04%
Regeneron Pharmaceuticals, Inc. logo
6.48%
-15.2%
-50.31%
-3.3%
-2.01%
Beone Medicines Ltd logo
1.77%
24.81%
62.78%
79.11%
29.69%
Vertex Pharmaceuticals Incorporated logo
-14.45%
-19.13%
-17.84%
34.68%
41.87%
Alnylam Pharmaceuticals, Inc. logo
13.79%
83.28%
75.87%
111.28%
242.25%

About Liminatus Pharma Inc

Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.
Organization
Liminatus Pharma
Employees
0
CEO
Mr. Chris Kim J.D., L.L.M.
Industry
Miscellaneous

Key Management of Liminatus Pharma Inc

NameTitle
Mr. Chris Kim J.D., L.L.M.
CEO & Chairman
Mr. Scott Dam
Chief Financial Officer
Dr. Beom Kyu Choi
Chief Technology Officer & Member of Scientific Advisory Board
Dr. Byong Chul Yoo Ph.D.
Chief Science Officer & Member of Scientific Advisory Board
Dr. Sang-jin Lee Ph.D.
Head of Research & Development and Member of Scientific Advisory Board

Important FAQs about investing in LIMN Stock from India :

What is Liminatus Pharma share price today?

Liminatus Pharma share price today is $2.74 as on at the close of the market. Liminatus Pharma share today touched a day high of $2.74 and a low of $2.64.

What is the 52 week high and 52 week low for Liminatus Pharma share?

Liminatus Pharma share touched a 52 week high of $33.66 and a 52 week low of $2.53. Liminatus Pharma stock price today i.e. is closed at $2.74, lower by 91.86% versus the 52 week high.

How to invest in Liminatus Pharma Stock (LIMN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Liminatus Pharma on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Liminatus Pharma Shares that will get you 0.5474 shares as per Liminatus Pharma share price of $2.74 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Liminatus Pharma Stock (LIMN) from India?

Indian investors can start investing in Liminatus Pharma (LIMN) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Liminatus Pharma stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Liminatus Pharma share’s latest price of $2.74 as on August 30, 2025 at 1:29 am IST, you will get 3.6496 shares of Liminatus Pharma. Learn more about fractional shares .

What are the returns that Liminatus Pharma has given to Indian investors in the last 5 years?

Liminatus Pharma stock has given -73.04% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?